Across TCGA pan-cancer cohorts, EP400P1 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated EP400P1 data layer compared with 4 for mutation status.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher EP400P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated EP400P1 expression acts as an unfavorable survival marker, although some lineages such as THYM and PAAD show a favorable association.

KIRC, ACC, and KICH are the cancer types where EP400P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.502	0.712	<.001	170	view →
ACC	DFS	Median	All	0.350	0.810	<.001	163	view →
KICH	DFS	Median	III,IV	0.208	0.951	<.001	79	view →
MESO	OS	Tertile	All	0.259	0.498	.002	70	view →
LGG	DFS	Median	All	0.662	0.810	<.001	53	view →
UVM	DFS	Quartile	III,IV	0.184	0.922	<.001	51	view →
COAD	OS	Median	All	0.732	0.873	.002	42	view →
LIHC	DFS	Median	All	0.456	0.644	<.001	37	view →
PRAD	DFS	Tertile	All	0.700	0.850	<.001	32	view →
LUSC	DFS	Tertile	III,IV	0.354	0.968	.002	22	view →
STAD	DFS	Median	IV	0.295	0.687	.015	15	view →
BLCA	OS	Quartile	IV	0.199	0.716	.007	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

Exploration

Same gene, other analysis: EP400P1 tumor-vs-normal RNA expression · all EP400P1 data types